G-DOC ® logo Fri Apr 25, 2014
register now |  forgot password



Cancer/Study Overview
Disease Study Count Patient Count Biospecimen Count Available Data Types
BREAST CANCER 27 3653 4566 PATIENT microRNA COPY NUMBER METABOLOMICS GENE EXPRESSION WGS CELL LINE
COLON CANCER 10 702 1365 PATIENT microRNA COPY NUMBER METABOLOMICS GENE EXPRESSION CELL LINE
LIVER CANCER 3 280 468 PATIENT microRNA COPY NUMBER GENE EXPRESSION
OVARIAN CANCER 1 283 564 PATIENT microRNA COPY NUMBER GENE EXPRESSION
PROSTATE CANCER 1 218 538 PATIENT microRNA COPY NUMBER GENE EXPRESSION
PANCREATIC CANCER 1 52 51 PATIENT GENE EXPRESSION
STOMACH CANCER 1 197 165 PATIENT GENE EXPRESSION
Total 44 5385 7717 PATIENT microRNA COPY NUMBER METABOLOMICS GENE EXPRESSION WGS CELL LINE
FINDINGS
NEWS
PUBLICATIONS

Seeking to identify the role of overexpression of c-myc in Topoisomerase II inhibition in human hepatocytes based on Reymann, et al. 2008  - loaded on: Thu Apr 12, 2012

Seeking to identify the role of AKR1C1 in Methotrexate resistance using HT29 colon cancer cell line by Selga, et al. 2008  - loaded on: Thu Apr 12, 2012

Seeking to identify the role of WIPF1-coexpressed gene signature as an alternative predictor of prognosis in colorectal cancer by Staub, et al. 2009  - loaded on: Thu Apr 12, 2012

Seeking to identify the role of NCOA2 in androgen receptor signalling in prostate cancer based on Taylor, et al. 2011  - loaded on: Thu Apr 12, 2012

Seeking to identify the role of copy number alterations associated with TMPRSS2-ERG fusion in prostate cancer based on Taylor, et al. 2011  - loaded on: Thu Apr 12, 2012

List of microRNAs which are independent prognostic factors in ER positive breast cancer cell based on Buffa, et al. 2011  - loaded on: Thu Apr 12, 2012

List of microRNAs which are independent prognostic factors in ER negative breast cancer cell based on Buffa, et al. 2011  - loaded on: Thu Apr 12, 2012

List of microRNAs whose differential expression distinguishes reciprocal basal-like and luminal-A breast cancer subtypes based on Enerly, et al. 2011  - loaded on: Thu Apr 12, 2012

List of microRNAs whose differential expression differentiates TP53 mutational status with TP53 wild type in primary human breast cancer by Enerly, et al.2011  - loaded on: Thu Apr 12, 2012

Seeking to identify genes involved in global regulation of ER alpha target genes based on Lin, et al. 2007  - loaded on: Thu Apr 12, 2012

List of one potential new target for treating a subset of hepatocelluar carcinomas based on Chiang, et al. 2008  - loaded on: Wed Aug 17, 2011

List of genes that can be used to classify G2 breast tumors into G2a (low grade) and G2b (high grade) subsets, which are similar in survival outcome to G1 and G3 tumors, respectively; validated in 2 separate cohorts based on Ivshina, et al. 2006  - loaded on: Wed Aug 17, 2011

List of genes which are associated with predicting metastatic colon cancer patient respondents to Cetuximab (anti-EGFR) based on Khambata-Ford, et al. 2007  - loaded on: Wed Aug 17, 2011

List of genes that define an expression signature which is able to distinguish p53 mutant and wild type breast tumors. The signature can be used to predict both prognosis and response to treatment based on Miller, et al. 2005  - loaded on: Wed Aug 17, 2011

List of genes that delineate 3 groups of breast cancer patients:one group of patients which will benefit from adjuvent therapy and two groups which will not, based on Pawitan, et al. 2005  - loaded on: Wed Aug 17, 2011

List of genes used in the differentiation of ER negative breast cancer patients who would expect to achieve pathologic complete response (pCR) from pre-operative adjuvant therapy and surgery from those who would not; based on Popovici, et al. 2010  - loaded on: Wed Aug 17, 2011

List of microRNAs within the C19MC (Chromosome 19 miRNA Cluster) that show significant upregulation as part of the subcategorization of subclasses of HCV-related hepatocellular carcinomas (HCC) based on Toffanin, et al. 2011  - loaded on: Wed Aug 17, 2011

List of miRNAs upregulated in subclass C3 HCV-related hepatocellular carcinomas based on miRNA expression analysis based on Toffanin, et al. 2011  - loaded on: Wed Aug 17, 2011

List of genes that are proposed as biomarkers for the progression of colorectal cancer (normal-adenoma-dysplasia-carcinoma) based on Galamb, et al. 2009  - loaded on: Wed Jan 19, 2011

List of genes whose expression can differentiate between normal colon and colon adenoma ("benign tumor") based on Galamb, et al. 2008  - loaded on: Wed Jan 19, 2011

List of genes that can be used to discriminate between colorectal cancer and normal colon tissue using mRNA expression analysis on biopsy samples based on Galamb, et al. 2008  - loaded on: Wed Jan 19, 2011

List of genes that differentiate normal colon tissue from colon adenomas based on Galamb, et al. 2010 produced via the application of a different analytic protocol (“PAM” – Prediction Analysis of Microarrays) performed on an older data set  - loaded on: Wed Jan 19, 2011

List of genes that differentiate normal colon tissue from colon cancer based on Galamb, et al. 2010 produced via the application of a different analytic protocol (“PAM” – Prediction Analysis of Microarrays) being performed on an older data set  - loaded on: Wed Jan 19, 2011

List of microRNAs (miRNAs) whose differential expression distinguishes colon tumor and normal colon tissue based on Sarver, et al. 2009  - loaded on: Wed Jan 19, 2011

List of miRNAs whose expression differentiates colon tumors with defective or proficient mismatch repair status based on Sarver, et al. 2009  - loaded on: Wed Jan 19, 2011

List of genes (putatively) from the WNT signaling pathway that are differentially expressed when comparing pedunculated adenomatous colon polyps and normal colon mucosa tissue based on Sabates, et al. 2007  - loaded on: Wed Jan 19, 2011

List of genes altered by copy number variation with a frequency that differentiates ER+ and ER- breast tumors that have the ERBB2 gene region amplified based on Sircoloumb, et al. 2010  - loaded on: Wed Jan 19, 2011

List of genes whose expression can be used to differentiate colon adenomas (a "benign tumor", but one with malignant potential) from colorectal adenocarcinoma based on Galamb, et al. 2008  - loaded on: Wed Jan 19, 2011

List of genes whose expression can be used to differentiate early and late stage colorectal adenocarcinoma based on Galamb, et al. 2008  - loaded on: Wed Jan 19, 2011

List of B-cell metagene components whose high expression is prognostic for longer metastasis-free survival in node-negative breast cancer patients with highly proliferative tumors based on Schmidt, et al. 2008  - loaded on: Tue Jan 18, 2011

List of 34 genes whose expression signature shows predictive properties for recurrence and death in patients with colorectal cancer based on Smith, et al. 2010  - loaded on: Tue Jan 18, 2011

List of six genes that form an overexpression signature that is strongly predictive for 1 year survival (55% vs. 91%) in patients with pancreatic ductal adenocarcinoma (PDAC) based on Stratford, et al. 2010  - loaded on: Tue Jan 18, 2011

List of genes that form a signature that reflects the pathological progression from dysplasia to hepatocellular carcinoma, based on Wurmbach, et al. 2007  - loaded on: Tue Jan 18, 2011

List of candidate driver genes located in focal deletions (<3Mb), most of which have decreased expression in a set of stage 2 colon cancer samples based on Brosens, et al. 2010  - loaded on: Tue Jan 18, 2011

List of candidate driver genes located in focal amplifications (<3Mb), most of which also have increased expression in a set of stage 2 colon cancer samples, based on Brosens, et al. 2010  - loaded on: Tue Jan 18, 2011

List of genes that form an expression signature that differentiates early and advanced hepatocellular carcinoma, all samples being HCV infected, based on Wurmbach, et al. 2007  - loaded on: Tue Jan 18, 2011

List of genes that form a signature that differentiates hepatic cell dysplasia from early hepatocellular carcinoma, all samples being HCV infected, based on Wurmbach, et al. 2007  - loaded on: Tue Jan 18, 2011

List of genes that are differentially expressed, as determined by microarray analysis, between resected pancreatic tumor tissue and normal tissue samples based on Pei, et al. 2009  - loaded on: Tue Jan 18, 2011

List of differentially expressed genes from breast tumor-derived, laser capture microdissected, stromal cells within the tumor mass; a subset of which helps distinguish patients expected to have a poor clinical outcome based on Finak, et al. 2008  - loaded on: Tue Jan 18, 2011

List of classifier genes for predicting distal relapse in Breast Cancer based on Loi, et al. 2008  - loaded on: Fri Sep 24, 2010

Seeking to identify candidate genes involved in hormone-stimulated growth of breast cancer based on Rae, et al. 2005  - loaded on: Thu Sep 23, 2010

List of genes to predict relapse in breast cancer patients treated with either Tamoxifen or Letrozole as determined by Desmedt, et al. 2009  - loaded on: Thu Sep 23, 2010

Seeking to find a method to improve clinical prognostics for histologic grade 2 breast cancer based on Sotiriou, et al. 2006  - loaded on: Thu Sep 23, 2010

Looking for a gene signature prognostic of distant metastatic relapse free survival in node negative breast cancer based on Wang, et al. 2005  - loaded on: Thu Sep 23, 2010

Investigating the list of genes with polymorphic variations that increase the risk of lung cancer based on Zheng, et al 2010  - loaded on: Wed Sep 22, 2010

Understanding the biological role of PTPN13 in Ewings Sarcoma based on Abaan, et al. 2005  - loaded on: Wed Sep 22, 2010

Understanding the role of GLI1 in Ewing’s Sarcoma family tumors (ESFT) based on Beauchamp, et al. 2009  - loaded on: Wed Sep 22, 2010

Evaluating the contribution of WNT signaling in Osteosarcoma based on Chen, et al. 2008  - loaded on: Wed Sep 22, 2010

Seeking to identify small molecule inhibitors of the Ewing’s Sarcoma family tumor (ESFT) for the gene list as determined by Erkizan, et al. 2009  - loaded on: Wed Sep 22, 2010

Seeking to identify the role of GREB1, a gene originally identified in breast cancer, in prostate cancer based on Rae, et al. 2006  - loaded on: Wed Sep 22, 2010

List of genes applied to a sample set of 198 node-negative breast cancer patients to predict distant metastatis within 5 years and hence the need for adjuvant therapy based on Desmedt, et al. 2007  - loaded on: Wed Sep 22, 2010

Testing the decreased proliferation of PPM1D in breast cancer based on Belova, et al. 2005  - loaded on: Wed Sep 22, 2010

Seeking to identify transcriptional targets for NF-kB regulation in breast cancer cells as determined by Park, et al. 2010  - loaded on: Wed Sep 22, 2010

Differentiating early and late relapsing subsets of node-negative, ER+ breast cancer patients treated with Tamoxifen based on Zhou, et al. 2007  - loaded on: Wed Sep 22, 2010

:Identifying the oncogenic effects of NCOA3 in lung, breast, and pancreatic cancer as determined by Lahusen, et al. 2007  - loaded on: Wed Sep 22, 2010

Identifying of the role of UBE3A in breast cancer as determined by Mani, et al. 2006  - loaded on: Wed Sep 22, 2010

Possible serum diagnostic markers for colon and pancreatic cancer as determined by Tassi, et al. 2006  - loaded on: Wed Sep 22, 2010

Understanding the significance of BLID for breast cancer based on Broustas, et al. 2010  - loaded on: Wed Sep 22, 2010

Investigating the molecular basis of drug resistance in pancreatic cancer based on Hong, et al. 2010  - loaded on: Wed Sep 22, 2010

Genes prognostic of renal cell carcinoma patient survival as determined by Kallakury, et al. 2001  - loaded on: Wed Sep 22, 2010

Genes with potential for therapeutic development in prostate cancer as determined by Park, et al. 2009  - loaded on: Wed Sep 22, 2010

Investigating to see if SOS1 is overexpressed for prostate cancer based on Timofeeva, et al. 2009  - loaded on: Wed Sep 22, 2010

Examining the role of GPER in breast cancer based on Ariazi, et al. 2010  - loaded on: Wed Sep 22, 2010

Investigating the elevated levels of FAP that worsen clinical outcome in pancreatic cancer based on Cohen, et al. 2008  - loaded on: Wed Sep 22, 2010

Investigating the effect of polymorphisms in the MBL2 on clinical outcome in lung cancer patients based on Pine, et al. 2007  - loaded on: Wed Sep 22, 2010

Identifying the role of the anti-apoptotic BCL2 in breast cancer as determined by Tabuchi, et al. 2009  - loaded on: Wed Sep 22, 2010

Understanding the mechanism of NCOA3 that represents a critical regulatory point for breast cancer based on Oh, et al. 2008  - loaded on: Wed Sep 22, 2010

Identifying genes that contribute to reduced tumor growth in brain and breast cancer based on Koller, et al. 2006  - loaded on: Wed Sep 22, 2010

Identifying a set of genes whose expression is altered in breast cancer as determined by Mewani, et al. 2006  - loaded on: Wed Sep 22, 2010

Understanding the interaction of XIAP with a well known gene RAF-1 in breast, lung, and pancreatic cancer based on Tian, et al. 2006  - loaded on: Wed Sep 22, 2010

investigating the role of TNFAIP8 in the pathogenesis of lung cancer based on Zhang, et al. 2005  - loaded on: Wed Sep 22, 2010

Genes that constitute provisional prognostic markers for survival in lung cancer as determined by Enewold, et al. 2009  - loaded on: Wed Sep 22, 2010

Exploring the elevated expression of the list of genes in malignant brain cancer as determined by Stylianou, et al. 2009  - loaded on: Wed Sep 22, 2010

Seeking to develop a better understanding of the role of differentiation and re-differentiation in breast cancer cells based on Sultan, et al. 2008  - loaded on: Wed Sep 22, 2010

List of breast cancer associated genes with hypermethylated promoters in healthy women based on Dumitrescu, et al. 2009  - loaded on: Thu Sep 2, 2010

Differentiating patients that will respond to tamoxifen therapy for Breast Cancer as determined by Zhang, et al. 2009  - loaded on: Wed Sep 1, 2010

Data-Type Overview
Data Type Study Count
PATIENT   PATIENT
35
microRNA   microRNA
8
GENE EXPRESSION   GENE EXPRESSION
41
CELL LINE   CELL LINE
9
WGS   WGS
1
METABOLOMICS   METABOLOMICS
4
COPY NUMBER   COPY NUMBER
8

G-DOC ® 2.0   |   RELEASE NOTES    |   powered by G-CODE
G-DOC ® at LCCC   |   SYSTEM REQUIREMENTS   |   PUBLICATION POLICY    |   DATA ACCESS POLICY   |   LICENSE INFO    |   CONTACT US   |   G-DOC ® TEAM
Lombardi Comprehensive Cancer Center logo Georgetown University logo Georgetown University Medical Center logo